SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues	$ 1,778	$ 1,739	$ 3,307	$ 3,250
Cost of Revenues:
Material and Labor	1,138	1,192	2,163	2,164
Other cost of revenues	327	216	539	463
Total Cost of Revenues	1,465	1,408	2,702	2,627
Research and development (R&D)
Share based compensation			5,940	5,349
Total Research and development	3,834	3,401	7,893	6,026
Selling and marketing (S&M)
Total Selling and marketing	4,172	1,445	6,922	2,682
General and administrative (G&A)
Total General and administrative	5,326	3,745	10,269	7,589
Financial Income (expenses), net;	(132)	351	162	733
Segment net Loss	(13,151)	(7,909)	(24,317)	(14,941)
Research and Development Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,120	668	1,974	1,351
Share based compensation	645	682	1,314	1,151
Clinical trials	1,125	1,166	2,287	1,949
Other R&D	944	885	2,318	1,575
Selling and Marketing Expense [Member]
Research and development (R&D)
Payroll and Benefits	2,779	793	4,757	1,615
Share based compensation	595	264	812	514
Selling and marketing (S&M)
Other S&M	798	388	1,353	553
General and Administrative Expense [Member]
Research and development (R&D)
Payroll and Benefits	1,729	818	3,309	1,648
Share based compensation	1,920	1,726	3,700	3,510
General and administrative (G&A)
Other G&A	$ 1,677	$ 1,201	$ 3,260	$ 2,431